Imagen 1 de 14
Galería
Imagen 1 de 14
CNS Neuroprotectio
USD280,00
Aproximadamente243,75 EUR
Estado:
Nuevo
Libro nuevo, sin usar y sin leer, que está en perfecto estado; incluye todas las páginas sin defectos. Consulta el anuncio del vendedor para obtener más información.
- ¡Cómpralo ya!CNS Neuroprotection by Frank W. Marcoux & Dennis Choi English Softcover Book New
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Envío:
Gratis USPS Media MailTM.
Ubicado en: Picayune, Mississippi, Estados Unidos
Entrega:
Entrega prevista entre el lun. 16 jun. y el lun. 23 jun. a 94104
Devoluciones:
No se aceptan devoluciones.
Pagos:
Compra con confianza
El vendedor asume toda la responsabilidad de este anuncio.
N.º de artículo de eBay:396058463328
Última actualización el 27 dic 2024 19:08:59 H.EspVer todas las actualizacionesVer todas las actualizaciones
Características del artículo
- Estado
- Book Title
- CNS Neuroprotection
- ISBN
- 9783642076251
Acerca de este producto
Product Identifiers
Publisher
Springer Berlin / Heidelberg
ISBN-10
3642076254
ISBN-13
9783642076251
eBay Product ID (ePID)
109292598
Product Key Features
Number of Pages
Xxii, 500 Pages
Publication Name
Cns Neuroprotection
Language
English
Publication Year
2010
Subject
Neurology, Life Sciences / Neuroscience, Pharmacology
Type
Textbook
Subject Area
Science, Medical
Series
Handbook of Experimental Pharmacology Ser.
Format
Trade Paperback
Dimensions
Item Weight
31 Oz
Item Length
9.3 in
Item Width
6.1 in
Additional Product Features
Intended Audience
Scholarly & Professional
Dewey Edition
21
Series Volume Number
155
Number of Volumes
1 vol.
Illustrated
Yes
Dewey Decimal
615/.5 s 616.8/0461
Table Of Content
Section I: Mechanic Approaches to CNS Neuroprotection.- 1 Blocking Excitotoxicity.- 2 Limiting Apoptosis as a Strategy for CNS Neuroprotection.- 3 Reducing Neuroinflammation.- 4 Mitochondrial Approaches to Neuroprotection.- 5 Stabilizing Calcium Homeostasis.- 6 Blocking Nitric Oxide Toxicity.- Section II: Neuroprotective Agents.- 7 Adenosine-Based Approaches to the Treatment of Neurodegenerative Disease.- 8 Sodium and Calcium Channel Blockers.- 9 Neuroprotection by Free Radical Scavengers and Other Antioxidants.- 10 Chemokines and Chemokine Receptors in the Central Nervous System: New Opportunities for Novel Therapeutics in Brain Ischemia and Trauma.- Section III: CNS Delivery of Neuroprotective Therapies.- 11 Ex Vivo Gene Therapy in the Central Nervous System.- 12 Developing Gene-Based Neuroprotection Strategies Using Herpes Amplicon Vectors.- Section IV: Disease Targetily of Newoportective Therapies.- 13 Stroke.- 14 Traumatic Central Nervous System Injury.- 15 Neurohormonal Signalling Pathways and the Regulation of Alzheimer ?-amyloid Metabolism Integrating Basic and Clinical Observations for Developing Successful Strategies to Delay, Retard or Prevent Cerebral Amyloidosis in Alzheimer's Disease.- 16 Amyotrophic Lateral Sclerosis.- 17 Therapeutics in Huntington's Disease.
Synopsis
"CNS neuroprotection" was a common subject of papers, symposia, and reviews during the previous "decade of the brain. " Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis- ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, "Mechanistic Approaches to CNS Neuroprotection," reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development, Ann Arbor Laboratories, outlines evidence supporting a contri- bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro- logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr., "CNS neuroprotection" was a common subject of papers, symposia, and reviews during the previous "decade of the brain. " Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, "Mechanistic Approaches to CNS Neuroprotection," reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr., This volume is a review which presents both a basic science and clinical perspective on neuroprotective approaches to acute and chronic neurodegenerative conditions. Experts from both fields review current areas of neuroprotection. The book describes basic science discovery in stroke research and the application of research within industry leading to the development of neuroprotective drugs.
LC Classification Number
RM300-666
Descripción del artículo del vendedor
Acerca de este vendedor
THE PLACE TO SHOP FIRST
100% de votos positivos•13 mil artículos vendidos
Registrado como vendedor particularPor tanto, no se aplican los derechos de los consumidores derivados de las leyes de protección de los consumidores de la UE. La Garantía al cliente de eBay sigue aplicando a la mayoría de compras. Más informaciónMás información
Votos de vendedor (7.157)
- 2***m (182)- Votos emitidos por el comprador.Mes pasadoCompra verificadaFast shipping. Packaged well. Item as described at a fair price.
- 3***9 (85)- Votos emitidos por el comprador.Mes pasadoCompra verificadaA very good experience as pictured and described, well packaged and on time delivery I would purchase from again.
- a***s (819)- Votos emitidos por el comprador.Último añoCompra verificadaA+++ SELLER!! Communication was very good, responded quickly and answered all questions about item. I was a little hesitant about purchase, but I’m so happy I made it. Item was as described and was a great value. I am very happy with this seller and my item! ⭐️⭐️⭐️⭐️⭐️🤩AO Smith 100238068 Water Softener Controller Transformer AO-WH-SOFT-450T NWOB (#375623494789)